According to the research report, the global cell and tissue preservation market size is expected to touch USD 9.54 Billion by 2030, from USD 3.95 Billion in 2022, growing with a significant CAGR of 11.6% from 2022 to 2030.
The cell and tissue preservation report
offers a comprehensive study of the current state expected at the major
drivers, market strategies, and key vendors’ growth. The report presents
energetic visions to conclude and study the market size, market hopes, and
competitive surroundings. The research also focuses on the important
achievements of the market, research & development, and regional growth of
the leading competitors operating in the market. The current trends of the
global cell and tissue preservation in conjunction with the geographical
landscape of this vertical have also been included in this report.
The report offers intricate dynamics about
different aspects of the global cell and tissue preservation market, which aids
companies operating in the market in making strategic development decisions.
The study also elaborates on significant changes that are highly anticipated to
configure growth of the global cell and tissue preservation during the forecast
period. It also includes a key indicator assessment that highlights growth
prospects of this market and estimates statistics related to growth of the
market in terms of value (US$ Mn) and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/1642
| Report Coverage | Details |
| Market Size by 2030 | USD 9.54 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 11.6% |
| Therapeutics Segment Market Share in 2021 | 40% |
| Tissue Segment Market Share in 2021 | 52% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Type, Application, Product, End User, Cell Provider, Geography |
This study covers a detailed segmentation
of the global cell and tissue preservation market, along with key information
and a competition outlook. The report mentions company profiles of players that
are currently dominating the global cell and tissue preservation market,
wherein various developments, expansions, and winning strategies practiced and
implemented by leading players have been presented in detail.
Key Players
- Thermo Fisher Scientific, Inc.
- Lonza
- BD
- MerckKGaA
- Cytiva
- Agilent Technologies, Inc.
- Avantor, Inc.
- FUJIFILM Irvine Scientific
- BioLifeSolutions Inc.
- AMSBIO
- Princeton CryoTech
- STEMCELL Technologies Inc.
- LGC SeraCare
- Corning Incorporated
- CellGenix GmbH
Market Segmentation
- Cell
- Mammalian Cells
- Others (Microorganisms and Plant Cells)
- Tissue
- Blood
- Bone
- Soft Tissues
- Skin
- Others
By Application
- Therapeutics
- Drug Discovery
- Gene therapy
- IVF treatment
- Cell therapy
- Research & Development
By Product
- Equipment
- Freezers
- Refrigerators
- Storage Systems
- Others
- Software
- Bio-preservation Media
- Home-brew Media
- Pre-formulated Media
By End User
- Biobanks
- Hospitals
By Cell Provider
- CD34+
- CD19+
- MSC
- iPSC
- hESC
- Tumor Cells
- Others
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Research Methodology
The research methodology adopted by
analysts for compiling the global cell and tissue preservation report is based
on detailed primary as well as secondary research. With the help of in-depth
insights of the market-affiliated information that is obtained and legitimated
by market-admissible resources, analysts have offered riveting observations and
authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary understanding
of the global cell and tissue preservation market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cell and Tissue Preservation Market
5.1. COVID-19 Landscape: Cell and Tissue Preservation Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Cell and Tissue Preservation Market, By Type
8.1. Cell and Tissue Preservation Market, by Type, 2022-2030
8.1.1. Cell
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Tissue
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Cell and Tissue Preservation Market, By Application Type
9.1. Cell and Tissue Preservation Market, by Application Type, 2022-2030
9.1.1. Therapeutics
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Drug Discovery
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Gene therapy
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. IVF treatment
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Research & Development
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Cell therapy
9.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Cell and Tissue Preservation Market, By Product Type
10.1. Cell and Tissue Preservation Market, by Product Type, 2022-2030
10.1.1. Equipment
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Software
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Bio-preservation Media
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Cell and Tissue Preservation Market, By End User Type
11.1. Cell and Tissue Preservation Market, by End User Type, 2022-2030
11.1.1. Biobanks
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Hospitals
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Cell and Tissue Preservation Market, By Cell Provider Type
12.1. Cell and Tissue Preservation Market, by Cell Provider, 2022-2030
12.1.1. CD34+
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. CD19+
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. MSC
12.1.3.1. Market Revenue and Forecast (2017-2030)
12.1.4. iPSC
12.1.4.1. Market Revenue and Forecast (2017-2030)
12.1.5. hESC
12.1.5.1. Market Revenue and Forecast (2017-2030)
12.1.6. Tumor Cells
12.1.6.1. Market Revenue and Forecast (2017-2030)
12.1.7. Others
12.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Cell and Tissue Preservation Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.2. Market Revenue and Forecast, by Application (2017-2030)
13.1.3. Market Revenue and Forecast, by Product (2017-2030)
13.1.4. Market Revenue and Forecast, by End User (2017-2030)
13.1.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Product (2017-2030)
13.1.6.4. Market Revenue and Forecast, by End User (2017-2030)
13.1.7. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.8.2. Market Revenue and Forecast, by Application (2017-2030)
13.1.8.3. Market Revenue and Forecast, by Product (2017-2030)
13.1.8.4. Market Revenue and Forecast, by End User (2017-2030)
13.1.8.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.3. Market Revenue and Forecast, by Product (2017-2030)
13.2.4. Market Revenue and Forecast, by End User (2017-2030)
13.2.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Product (2017-2030)
13.2.7. Market Revenue and Forecast, by End User (2017-2030)
13.2.8. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Product (2017-2030)
13.2.10. Market Revenue and Forecast, by End User (2017-2030)
13.2.11. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.12.3. Market Revenue and Forecast, by Product (2017-2030)
13.2.12.4. Market Revenue and Forecast, by End User (2017-2030)
13.2.13. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.14.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Product (2017-2030)
13.2.14.4. Market Revenue and Forecast, by End User (2017-2030)
13.2.15. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.3. Market Revenue and Forecast, by Product (2017-2030)
13.3.4. Market Revenue and Forecast, by End User (2017-2030)
13.3.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Product (2017-2030)
13.3.6.4. Market Revenue and Forecast, by End User (2017-2030)
13.3.7. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Product (2017-2030)
13.3.8.4. Market Revenue and Forecast, by End User (2017-2030)
13.3.9. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Product (2017-2030)
13.3.10.4. Market Revenue and Forecast, by End User (2017-2030)
13.3.10.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.11.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Product (2017-2030)
13.3.11.4. Market Revenue and Forecast, by End User (2017-2030)
13.3.11.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.3. Market Revenue and Forecast, by Product (2017-2030)
13.4.4. Market Revenue and Forecast, by End User (2017-2030)
13.4.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Product (2017-2030)
13.4.6.4. Market Revenue and Forecast, by End User (2017-2030)
13.4.7. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Product (2017-2030)
13.4.8.4. Market Revenue and Forecast, by End User (2017-2030)
13.4.9. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Product (2017-2030)
13.4.10.4. Market Revenue and Forecast, by End User (2017-2030)
13.4.10.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.11.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Product (2017-2030)
13.4.11.4. Market Revenue and Forecast, by End User (2017-2030)
13.4.11.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.2. Market Revenue and Forecast, by Application (2017-2030)
13.5.3. Market Revenue and Forecast, by Product (2017-2030)
13.5.4. Market Revenue and Forecast, by End User (2017-2030)
13.5.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Product (2017-2030)
13.5.6.4. Market Revenue and Forecast, by End User (2017-2030)
13.5.7. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Application (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Product (2017-2030)
13.5.8.4. Market Revenue and Forecast, by End User (2017-2030)
13.5.8.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
Chapter 14. Company Profiles
14.1. Thermo Fisher Scientific, Inc.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Lonza
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. BD
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. MerckKGaA
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Cytiva
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Agilent Technologies, Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Avantor, Inc.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. FUJIFILM Irvine Scientific
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. BioLifeSolutions Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. AMSBIO
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
14.11. Princeton CryoTech
14.11.1. Company Overview
14.11.2. Product Offerings
14.11.3. Financial Performance
14.11.4. Recent Initiatives
14.12. STEMCELL Technologies Inc.
14.12.1. Company Overview
14.12.2. Product Offerings
14.12.3. Financial Performance
14.12.4. Recent Initiatives
14.13. LGC SeraCare
14.13.1. Company Overview
14.13.2. Product Offerings
14.13.3. Financial Performance
14.13.4. Recent Initiatives
14.14. Corning Incorporated
14.14.1. Company Overview
14.14.2. Product Offerings
14.14.3. Financial Performance
14.14.4. Recent Initiatives
14.15. CellGenix GmbH
14.15.1. Company Overview
14.15.2. Product Offerings
14.15.3. Financial Performance
14.15.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments